Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy-Reference-Cited by-同舟云学术

Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy

Published:2015-05-15 Issue:8 Volume:29 Page:903-910
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Alwan Ferras,He Annie,Montoto Silvia,Kassam Shireen,Mee Matthew,Burns Fiona,Edwards Simon,Wilson Andrew,Tenant-Flowers Melinda,Marcus Robert,Ardeshna Kirit M.,Bower Mark,Cwynarski Kate

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference28 articles.

1. Disease progression and survival following specific AIDS-defining conditions: a retrospective cohort study of 2048 HIV-infected persons in London.;Petruckevitch;AIDS,1998

2. Burkitt lymphoma in adults.;Perkins;Hematology Am Soc Hematol Educ Program,2008

4. HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era.;Montoto;J Clin Oncol,2012

5. HIV status does not impair the outcome of patients diagnosed with diffuse large B-cell lymphoma treated with R-CHOP in the cART era.;Coutinho;AIDS,2014

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune deficiency/dysregulation -associated lymphoproliferative disorders. Revised classification and management;Blood Reviews;2024-03

2. Plasmablastic Lymphoma. A State-of-the-Art Review: Part 2-Focus on therapy;Mediterranean Journal of Hematology and Infectious Diseases;2024-02-29

3. Clinical characteristics and outcomes of newly diagnosed patients with human immunodeficiency virus-associated Burkitt lymphoma: the Central and Western China AIDS lymphoma league 002 study (CALL-002 study);Infectious Agents and Cancer;2023-12-05

4. Outcomes of human immunodeficiency virus‐associated Burkitt lymphoma and diffuse large B‐cell lymphoma treated in Australia: A report from the Australasian Lymphoma Alliance;British Journal of Haematology;2023-03-03

5. Plasmablastic Lymphoma;Reference Module in Biomedical Sciences;2023